Floatz logo

Valproic Acid

Bipolar Disorder

University of New MexicoSmall moleculePhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
73/ 100

Competitive context

61 Active assets in the Bipolar Disorder cohort.

Asset / SponsorPhaseRating
Asenapine
Dr. Stavroula Rakitzi
Phase 4BBB
CITALOPRAM
University of Texas Southwestern Medical Center
Phase 4BBB
QUETIAPINE
First Affiliated Hospital of Zhejiang University
Phase 4BBB
Paroxetine
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Phase 4BBB
Lamotrigine
Johns Hopkins University
Phase 4BBB

View all 50 →

Same molecule, other indications

Valproic Acid is also rated in:

bipolar I disorderActive
BBB
Indicative · Phase 4
74 / 100
View asset →
epilepsyActive
BBB
Indicative · Phase 4
73 / 100
View asset →
traumatic brain injuryActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →